|Last Price$33.93||Day Change (%)-3.44%|
|Open Price$35.28||Day Change ($)-1.21|
|Day Range33.91–35.35||52-Week Range21.44–36.99|
As of Fri 9/30/2016 5:02:00 PM | USD
Scientists Honored for Hep C Research
Global Hepatitis B and C Diagnostics Market to Witness Growth Through 2020 Due to Concerted Efforts of Health Organisations, Reports Technavio
UPDATE: How Gilead 'broke' Obamacare
Dynavax stock drops then gains 30% after canceled FDA drug review confounds investors
Though midstream energy's shifting fundamentals challenge Boardwalk, these same changes create opportunities for the majority of pipeline operators we cover.
Marsico Capital CEO Tom Marsico favors the growth prospects of these biotech companies that are producing novel drugs for unmet medical needs.